Members of the league work with elementary students across the country to give them a sense of belonging to the veterinary profession. “I’m most proud of bringing people together who share the mission and vision with all their heart,” Pink Phoenix remarks. “Nobody can just be a member of the league. You have to earn the cape.” The league has over 400 certified role models throughout the country who are either veterinarians—VetaHumanz—or veterinary school students—VetaHumanz in training.
Over the past 2 years, you’ve probably heard a lot about the spread of SARS-CoV-2—the virus that causes COVID-19—and the emergence of variants. The discovery and tracking of these variants is possible thanks to genomic surveillance, a technique that involves sequencing and analyzing the genomes of SARS-CoV-2 virus particles from many COVID-19 patients. Genomic surveillance has not only shed light on how SARS-CoV-2 has evolved and spread, but it has also helped public health officials decide when to introduce measures to help protect people.
In December 2021, the NIGMS-supported SARS-CoV-2 genomic surveillance program at the University of New Mexico Health Science Center (UNM HSC) in Albuquerque detected the first known case of the Omicron variant in the state, which enabled a rapid public health response. The program’s co-leaders, assistant professors Darrell Dinwiddie, Ph.D., and Daryl Domman, Ph.D., were watching on high alert for it to enter New Mexico, and when it did, they were poised to quickly identify it:
NIGMS is pleased to bring you Pathways: The Vaccine Science Issue [PDF], which explains how the messenger RNA (mRNA) vaccines for COVID-19 work and how they were developed. Building on years of research, scientists were able to create these vaccines, thoroughly test them, and get them to the public as quickly as possible—while still making sure they were safe and effective.
Pathways, designed for students in grades 6 through 12, aims to build awareness of basic biomedical science and its importance to health while inspiring careers in research. All materials in the collection are available online for free.
Dr. Ramos-Benítez researches interactions between pathogens—such as the viruses that cause Ebola and COVID-19—and their hosts. He’s also the founder and president of Ciencia en tus Manos (“Science in Your Hands”), a nonprofit organization that presents scientific information in Spanish and aims to provide a community to support the next generation of scientists.
Navajo students are contributing to public health efforts in diabetes, COVID-19, domestic violence, and maternal and child health through the Navajo Native American Research Center for Health (NARCH) Partnership. “Our goal is to really enhance the educational pathways available to Navajo students from high school to graduate school and beyond,” says Mark Bauer, Ph.D., a co-director of the Navajo NARCH Partnership and professor at Diné College—a tribal college on the Navajo Nation. (Diné means “the people” and is how Navajo people refer to themselves in their native language.)
ACTIV clinical trials will evaluate the safety and efficacy of COVID-19 treatments and vaccines. Credit: iStock.
Since the virus that causes COVID-19, known as SARS-CoV-2, was first reported in late 2019, scientists have launched hundreds of studies on strategies for diagnosis, prevention, and treatment. To prioritize the most promising vaccine and therapeutics candidates, streamline clinical trials, and coordinate regulatory processes, the National Institutes of Health (NIH) and the Foundation for the NIH have established the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership. ACTIV brings together eight government entities, 20 biopharmaceutical companies, and four nonprofit organizations.
Spike proteins on the surface of a coronavirus. Credit: David Veesler, University of Washington.
Since the start of the COVID-19 pandemic, researchers from many areas of biomedical science have worked together to learn how this new disease affects the human body, how to prevent its spread, and how to treat it. Severe cases of COVID-19 and cases of sepsis share many symptoms. Sepsis is the body’s overactive and extreme response to an infection. It’s unpredictable and can progress rapidly. Without prompt treatment, it can lead to tissue damage, organ failure, and death.
Sepsis has similarities with some cases of COVID-19, most likely because the two conditions trigger the same reactions at the cellular level. Researchers have studied these reactions in sepsis for many years.
“When we look back on 2020 and the speed with which progress was made against COVID-19, two features will stand out,” says John Younger, M.D., a member of the NIGMS Advisory Council who recently co-chaired a working group on advancing sepsis research. “The first is how quickly the biotechnology community came together to develop vaccine candidates. The second, and arguably the most immediately impactful, is how caregivers and clinical researchers were able to rapidly refine the care of COVID-19 patients based on decades of experience with sepsis.”
This post highlights a few of the many sepsis researchers supported by NIGMS who are applying their expertise to COVID-19.
Recent news headlines are awash in references to “modeling the spread” and “flattening the curve.” You may have wondered what exactly this means and how it applies to the COVID-19 pandemic. Infectious disease modeling is part of the larger field of computer modeling. This type of research uses computers to simulate and study the behavior of complex systems using mathematics, physics, and computer science. Each model contains many variables that characterize the system being studied. Simulation is done by adjusting each of the variables, alone or in combination, to see how the changes affect the outcomes. Computer modeling is used in a wide array of applications, from weather forecasting, airplane flight simulation, and drug development to infectious disease spread and containment.